Elevated blood levels of Lp-PLA2 activity were associated with increased risk of recurrent vascular events in patients with TIA or primary ischemic stroke, whereas elevated Lp-PLA2 mass levels were related to the risk of stroke in the general population. This evidence concerns the gene PLA2G7 and stroke disorder.